Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway

Paclitaxel (PTX) is widely used in the front-line chemotherapy for gastric cancer (GC), but resistance limits its use. Due to the lack of proper models, mechanisms underlying PTX resistance in GC were not well studied. Using established PTX-resistant GC cell sublines HGC-27R, we for the first time i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Chen, Dongshao, Lin, Xiaoting, Zhang, Cheng, Liu, Zhentao, Chen, Zuhua, Li, Zhongwu, Wang, Jingyuan, Li, Beifang, Hu, Yanting, Dong, Bin, Shen, Lin, Ji, Jiafu, Gao, Jing, Zhang, Xiaotian
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833539/
https://ncbi.nlm.nih.gov/pubmed/29374144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0132-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados